According to WuXi Biologics's latest financial reports the company's current revenue (TTM) is $2.21 B. In 2022 the company made a revenue of $2.21 B an increase over the years 2021 revenue that were of $1.61 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 | $2.21 B | 37.09% |
2021 | $1.61 B | 87.66% |
2020 | $0.86 B | 50.9% |
2019 | $0.57 B | 54.74% |
2018 | $0.36 B | 48.1% |
2017 | $0.24 B | 74.7% |
2016 | $0.14 B | 65.72% |
2015 | $85.94 M | 60.37% |
2014 | $53.59 M |